Congying Xia1, Marleen Vonder2, Grigory Sidorenkov2, Matthijs Oudkerk3, Jan Cees de Groot1, Pim van der Harst4, Geertruida H de Bock2, Peter Paul De Deyn5, Rozemarijn Vliegenthart1. 1. University of Groningen, University Medical Center Groningen, Department of Radiology. 2. University of Groningen, University Medical Center Groningen, Department of Epidemiology. 3. University of Groningen, Faculty of Medical Sciences. 4. University of Groningen, University Medical Center Groningen, Department of Cardiology. 5. University of Groningen, University Medical Center Groningen, Department of Neurology, Alzheimer Center Groningen.
Abstract
AIM: Coronary artery disease (CAD) and cognitive impairment are common in the elderly, with evidence for shared risk factors and pathophysiological processes. The coronary artery calcium (CAC) score is a marker of subclinical CAD, which may allow early detection of individuals prone to cognitive decline. Prior studies on associations of CAC and clinical CAD with cognitive impairment had discrepant results. This systematic review aims to evaluate the association of (sub)clinical CAD with cognitive function, cognitive decline, and diagnosis of mild cognitive impairment (MCI) or dementia. METHODS: A systematic search was conducted in MEDLINE, Embase, and Web of Science until February 2019, supplemented with citations tracking. Two reviewers independently screened studies and extracted information including odds ratios (ORs) and hazard ratios (HRs). RESULTS: Forty-six studies, 10 on CAC and 36 on clinical CAD, comprising 1,248,908 participants were included in the systematic review. Studies about associations of (sub)clinical CAD with cognitive function and cognitive decline had heterogeneous methodology and inconsistent findings. Two population-based studies investigated the association between CAC and risk of dementia over 6-12.2 years using different CAC scoring methods. Both found a tendency toward higher risk of dementia as CAC severity increased. Meta-analysis in 15 studies (663,250 individuals) showed an association between CAD and MCI/dementia (pooled OR 1.32, 95%CI 1.17-1.48) with substantial heterogeneity (I2=87.0%, p＜0.001). Pooled HR of CAD for incident MCI/dementia over 3.2-25.5 years in six longitudinal studies (70,060 individuals) was 1.51 (95%CI 1.24-1.85), with low heterogeneity (I2=14.1%, p=0.32). Sensitivity analysis did not detect any study that was of particular influence on the pooled OR or HR. CONCLUSIONS: Limited evidence suggests the CAC score is associated with risk of dementia. In clinical CAD, risk of MCI and dementia is increased by 50%, as supported by stronger evidence.
AIM: Coronary artery disease (CAD) and cognitive impairment are common in the elderly, with evidence for shared risk factors and pathophysiological processes. The coronary artery calcium (CAC) score is a marker of subclinical CAD, which may allow early detection of individuals prone to cognitive decline. Prior studies on associations of CAC and clinical CAD with cognitive impairment had discrepant results. This systematic review aims to evaluate the association of (sub)clinical CAD with cognitive function, cognitive decline, and diagnosis of mild cognitive impairment (MCI) or dementia. METHODS: A systematic search was conducted in MEDLINE, Embase, and Web of Science until February 2019, supplemented with citations tracking. Two reviewers independently screened studies and extracted information including odds ratios (ORs) and hazard ratios (HRs). RESULTS: Forty-six studies, 10 on CAC and 36 on clinical CAD, comprising 1,248,908 participants were included in the systematic review. Studies about associations of (sub)clinical CAD with cognitive function and cognitive decline had heterogeneous methodology and inconsistent findings. Two population-based studies investigated the association between CAC and risk of dementia over 6-12.2 years using different CAC scoring methods. Both found a tendency toward higher risk of dementia as CAC severity increased. Meta-analysis in 15 studies (663,250 individuals) showed an association between CAD and MCI/dementia (pooled OR 1.32, 95%CI 1.17-1.48) with substantial heterogeneity (I2=87.0%, p＜0.001). Pooled HR of CAD for incident MCI/dementia over 3.2-25.5 years in six longitudinal studies (70,060 individuals) was 1.51 (95%CI 1.24-1.85), with low heterogeneity (I2=14.1%, p=0.32). Sensitivity analysis did not detect any study that was of particular influence on the pooled OR or HR. CONCLUSIONS: Limited evidence suggests the CAC score is associated with risk of dementia. In clinical CAD, risk of MCI and dementia is increased by 50%, as supported by stronger evidence.
Authors: Kathleen M Hayden; Peter P Zandi; Constantine G Lyketsos; Ara S Khachaturian; Lori A Bastian; Gene Charoonruk; JoAnn T Tschanz; Maria C Norton; Carl F Pieper; Ron G Munger; John C S Breitner; Kathleen A Welsh-Bohmer Journal: Alzheimer Dis Assoc Disord Date: 2006 Apr-Jun Impact factor: 2.703
Authors: Akira Fujiyoshi; David R Jacobs; Annette L Fitzpatrick; Alvaro Alonso; Daniel A Duprez; A Richey Sharrett; Teresa Seeman; Michael J Blaha; José A Luchsinger; Stephen R Rapp Journal: Circ Cardiovasc Imaging Date: 2017-05 Impact factor: 7.792
Authors: Philip B Gorelick; Angelo Scuteri; Sandra E Black; Charles Decarli; Steven M Greenberg; Costantino Iadecola; Lenore J Launer; Stephane Laurent; Oscar L Lopez; David Nyenhuis; Ronald C Petersen; Julie A Schneider; Christophe Tzourio; Donna K Arnett; David A Bennett; Helena C Chui; Randall T Higashida; Ruth Lindquist; Peter M Nilsson; Gustavo C Roman; Frank W Sellke; Sudha Seshadri Journal: Stroke Date: 2011-07-21 Impact factor: 7.914
Authors: Miia Kivipelto; Eeva-Liisa Helkala; Mikko P Laakso; Tuomo Hänninen; Merja Hallikainen; Kari Alhainen; Susan Iivonen; Arto Mannermaa; Jaakko Tuomilehto; Aulikki Nissinen; Hilkka Soininen Journal: Ann Intern Med Date: 2002-08-06 Impact factor: 25.391
Authors: Donald M Lyall; Carlos A Celis-Morales; Jana Anderson; Jason M R Gill; Daniel F Mackay; Andrew M McIntosh; Daniel J Smith; Ian J Deary; Naveed Sattar; Jill P Pell Journal: Eur Heart J Date: 2017-02-21 Impact factor: 29.983
Authors: Olga V Zimnitskaya; Marina M Petrova; Natalia V Lareva; Marina S Cherniaeva; Mustafa Al-Zamil; Anastasia E Ivanova; Natalia A Shnayder Journal: Genes (Basel) Date: 2022-07-12 Impact factor: 4.141
Authors: Tenielle Porter; Marc Sim; Richard L Prince; John T Schousboe; Catherine Bondonno; Wai H Lim; Kun Zhu; Douglas P Kiel; Jonathan M Hodgson; Simon M Laws; Joshua R Lewis Journal: Lancet Reg Health West Pac Date: 2022-06-26
Authors: Suvasini Lakshmanan; April Kinninger; Ilana Golub; Suraj Dahal; Divya Birudaraju; Khadije Ahmad; Ahmad K Ghanem; Vahid Rezvanizadeh; Sion K Roy; Matthew J Budoff Journal: Am J Prev Cardiol Date: 2020-10-21